The first annual financial results of Xofigo (radium-223 dichloride) from Bayer are in line with the MEDraysintell analysis showing that the growth of nuclear medicine in the future will come through therapeutic radiopharmaceuticals (radiotherapeutics). Revenue for Xofigo – a product used in the treatment of prostate and bone cancers – reached EUR 157 million (US$ 209 million) in 2014.

Carestream is demonstrating its new Touch Ultrasound System at the American Institute of Ultrasound in Medicine (AIUM) annual meeting, March 21-25.

Treating metastatic melanoma with radiation therapy and two immunotherapies targeting the CTLA4 and PD-1 pathways could elicit an optimal response in more patients, boosting the immune system’s attack on the disease, suggests a new study. The study, from a multidisciplinary team of researchers from Penn’s Abramson Cancer Center, was published in Nature.

BC Technical, the nation's leading non-OEM provider of Medical Imaging Solutions, has acquired Eclipse Systems, a nuclear imaging service company providing systems, parts and customized service solutions. As part of their ongoing vision to provide the best, and most comprehensive service at an affordable rate, BC Technical continues to expand their reach and expertise. This strategic acquisition allows BC Technical to add valuable resources and knowledge in addition to strengthening their capabilities, specifically within Nuclear Medicine and Molecular Imaging.

Purview announced delivery of Purview ViTA, a secure Web-based patient consult platform. The platform provides a HIPAA-compliant, secure environment for quick and efficient sharing of complete patient medical records, including medical images, with experts at healthcare facilities across the world, without having to penetrate secure firewalls or other restrictive technology.

Hitachi Medical Systems Europe announced the next generation of Oasis, the open high-field 1.2T magnetic resonance imaging (MRI) system, at ECR 2015. New features help to overcome obstacles and prevent delays while optimizing workflow management and costs. Easy patient access makes OASIS highly suitable for interventional procedures.

The Centers for Medicare and Medicaid Services (CMS) has released the 2015 National Impact Assessment of Quality Measures Report (2015 Impact Report).

A new research technology was profiled during scientific sessions at the European Congress of Radiology (ECR) in Vienna, Austria. Densitas Research Edition assesses mammographic breast density using ‘for presentation’ digital mammography images.